ID   HSM-2
AC   CVCL_M512
DR   Wikidata; Q54896456
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2064960;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgM kappa.
CC   Characteristics: IL6 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York (2000).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=2064960; DOI=10.1111/j.1365-2141.1991.tb04419.x;
RA   Kobayashi M., Miyagishima T., Imamura M., Maeda S., Gotohda Y.,
RA   Iwasaki H., Sakurada K., Miyazaki T.;
RT   "Establishment and characterization of a plasma cell leukaemia cell
RT   line dependent for growth on IL-6 and a bi-phenotypic subclone
RT   dependent upon both IL-3 and IL-6.";
RL   Br. J. Haematol. 78:217-221(1991).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//